Sinclair non-exec takes more shares
A round-up of the biggest director buys today so far.
Jean-Charles Tschudin, a non-executive director at the skin care products supplier Sinclair Pharma, has added to his holding in the company with the purchase of 56,000 shares at 36p a time.
He now has 967,117 shares, which is about 0.4% of the company.
Top Director Buys
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Qatar Investment Fund (QIF) Director name: Mr David von SimsonAmount purchased: 75,000 @ $0.93 Value: $69,750
Sinclair Pharma (SPH) Director name: Mr Jean-Charles TschudinAmount purchased: 56,000 @ 36.00p Value: £20,160
Witan Inv Trust (WTAN) Director name: Mr Robert W BoyleAmount purchased: 2,024 @ 525.00p Value: £10,626
Top Director Sells
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Millions of pension savers could get targeted support under new proposals
The proposals are part of the FCA’s attempt to tackle the advice gap, after 75% of savers admitted they don’t have a clear plan for their pension
By Katie Williams Published
-
RICS: Housing market continues to strengthen but 2025 could be challenging
The latest survey by the Royal Institution of Chartered Surveyors reports a resilient UK housing market, but warns of headwinds next year
By Ruth Emery Published